BECTON, DICKINSON AND COMPANY Segment Expenditure Addition To Long Lived Assets
BECTON, DICKINSON AND COMPANY (BDX) reported Segment Expenditure Addition To Long Lived Assets of $108.00 million for the 3-month period ending 2025-12-31, per its 10-Q filed 2026-02-09.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentExpenditureAdditionToLongLivedAssets · last filed 2026-02-09
- BECTON, DICKINSON AND COMPANY segment expenditure addition to long lived assets for the quarter ending 2025-12-31 was $108.00M, a 2.86% increase year-over-year.
- BECTON, DICKINSON AND COMPANY segment expenditure addition to long lived assets for the quarter ending 2024-12-31 was $105.00M.
- BECTON, DICKINSON AND COMPANY segment expenditure addition to long lived assets for fiscal 2025 was $760.00M, a 4.83% increase from fiscal 2024.
- BECTON, DICKINSON AND COMPANY segment expenditure addition to long lived assets for fiscal 2024 was $725.00M, a 17.05% decline from fiscal 2023.
- BECTON, DICKINSON AND COMPANY segment expenditure addition to long lived assets for fiscal 2023 was $874.00M, a 10.17% decline from fiscal 2022.
- BECTON, DICKINSON AND COMPANY segment expenditure addition to long lived assets for fiscal 2022 was $973.00M, a 18.51% decline from fiscal 2021.
| Period end | Segment Expenditure Addition To Long Lived Assets 3 month | Segment Expenditure Addition To Long Lived Assets 12 month |
|---|---|---|
| 2025-12-31 | $108.00M 10-Q · filed 2026-02-09 | |
| 2025-09-30 | $760.00M 10-K · filed 2025-11-25 | |
| 2024-12-31 | $105.00M 10-Q · filed 2026-02-09 | |
| 2024-09-30 | $725.00M 10-K · filed 2025-11-25 | |
| 2023-09-30 | $874.00M 10-K · filed 2025-11-25 | |
| 2022-09-30 | $973.00M 10-K · filed 2024-11-27 | |
| 2021-09-30 | $1.19B 10-K · filed 2023-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |